Sweat Test Device for Cystic Fibrosis

(SWEAT CF Trial)

This trial tests a new sweat test device to aid in diagnosing cystic fibrosis (CF). The device, called the micro Sweat Test Patch (µSTP), will be compared to the standard sweat testing method. It aims to measure sweat chloride levels quickly and easily, which is crucial for CF diagnosis. Individuals with an existing CF diagnosis or newborns with high Immunoreactive Trypsinogen (IRT) levels are suitable participants, provided they do not have skin issues like eczema. The study takes place at cystic fibrosis clinics in Atlanta. As an unphased trial, it offers participants the chance to contribute to innovative diagnostic advancements in CF care.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.

Research has shown that the micro Sweat Test Patch (mSTP) is generally safe for people. This patch uses tiny needles to deliver pilocarpine, a substance that induces sweating, and studies have found it is well-tolerated by healthy adults. The same technology has been used to test sweat chloride levels, aiding in the diagnosis of cystic fibrosis.

Past research demonstrated that the patch can safely and effectively collect sweat with minimal discomfort or side effects. In children, the rate of insufficient sweat collection, an important safety measure, was less than 10%, meeting recommended standards. This indicates the device is reliable and safe for most users, including young children and infants.

Researchers are excited about the micro Sweat Test Patch (µSTP) for cystic fibrosis because it offers a more streamlined and potentially faster method for measuring sweat chloride levels, which are crucial for diagnosing and managing the condition. Unlike the standard method that requires manual sweat collection and lab analysis, the µSTP automatically collects sweat and continuously reads chloride values through its microfluidics channel. This innovation could lead to quicker, more efficient testing with less room for error, which is a significant advantage over the traditional, more cumbersome process.

Research has shown that the micro Sweat Test Patch (µSTP), which participants in this trial may use, is a promising tool for measuring sweat chloride levels, crucial for diagnosing cystic fibrosis (CF). Studies have found that tiny needle patches with pilocarpine nitrate can induce sweating without traditional methods. This wearable patch continuously tracks sweat chloride levels through tiny channels, providing real-time information. Data from earlier tests suggest that this method is accurate and may make sweat testing easier and more comfortable for CF patients. The trial will compare the µSTP with the standard method, which involves inducing sweat using iontophoresis and collecting it for analysis. This approach could simplify CF management by allowing patients to monitor their condition at home.¹³⁴⁶⁷